Publications by authors named "Annelie Musters"

Claim this Profile
I
Impact of COVID-19 disease and vaccination on dermatological immune-mediated inflammatory diseases atopic dermatitis, psoriasis, and vitiligo: a Target2B! substudy.
Nicoline F van Buchem-Post, Wouter Ouwerkerk, Eileen W Stalman, Koos P J van Dam, Luuk Wieske, Annelie H Musters

J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study.
Anouk G M Caron, Astrid M van Huizen, Annelie A H Musters, Louise A A Gerbens, Maritza A Middelkamp Hup

J Eur Acad Dermatol Venereol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The UPDATE trial (UVB Phototherapy in Dermatology for Atopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.
Eva Knöps, Phyllis Spuls, Ruben Duijnhoven, Marcel Dijkgraaf, Marit van Barreveld, Annelie Musters

Trials· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
Angelo Li, Annelie H Musters, Ariënna Hyseni, Louise A A Gerbens, Phyllis I Spuls

Br J Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Eileen W Stalman, Luuk Wieske, Jim B D Keijser, Koos P J van Dam, Laura Y L Kummer, Annelie H Musters

J Allergy Clin Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Anika M Valk, Jim B D Keijser, Koos P J van Dam, Eileen W Stalman, Luuk Wieske, Annelie H Musters

Allergy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.
Eva Knöps, Phyllis Spuls, Ruben Duijnhoven, Marcel Dijkgraaf, Marit van Barreveld, Annelie Musters

Trials· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling.
Astrid van Huizen, Paul Bank, Gayle van der Kraaij, Annelie Musters, Celine Busard

J Invest Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Luuk Wieske, Eileen W Stalman, P J Koos van Dam, Laura Y Kummer, Maurice Steenhuis, Annelie H Musters

Ann Rheum Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
Koos P J van Dam, Adriaan G Volkers, Luuk Wieske, Eileen W Stalman, Laura Y L Kummer, Annelie H Musters

BMC Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry.
Annelie H Musters, Conor Broderick, David Prieto-Merino, Andrea Chiricozzi, Giovanni Damiani

J Eur Acad Dermatol Venereol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, Laura Y L Kummer, Jesse Roosen, Annelie H Musters

J Autoimmun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce.
Angela L Bosma, Annelie H Musters, Manja Bloem, Louise A A Gerbens, Maritza A Middelkamp-Hup

J Eur Acad Dermatol Venereol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Eileen W Stalman, Luuk Wieske, Koos P J van Dam, Laura Y Kummer, Zoé L E van Kempen, Annelie H Musters

Ann Rheum Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis: First-Year Results of a Single-Blind Randomized Controlled Trial.
Gayle van der Kraaij, Celine Busard, Juul van den Reek, Stef Menting, Annelie Musters

J Invest Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From the Cochrane Library: Phototherapy for atopic eczema.
Katie A O'Connell, Lori S Kim, Mindy D Szeto, Torunn Sivesind, Robert P Dellavalle, Annelie H Musters

J Am Acad Dermatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Laura Boekel, Eileen W Stalman, Luuk Wieske, Femke Hooijberg, Koos P J van Dam, Annelie H Musters

Lancet Rheumatol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, Eileen W Stalman, Laura Y L Kummer, Annelie H Musters

Lancet Rheumatol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
Luuk Wieske, Laura Y L Kummer, Koos P J van Dam, Eileen W Stalman, Anneke J van der Kooi, Annelie H Musters

BMC Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning from disease registries during a pandemic: Moving toward an international federation of patient registries.
Dmitri Wall, Raed Alhusayen, Bernd Arents, Christian Apfelbacher, Esther A Balogh, Annelie Musters

Clin Dermatol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phototherapy for atopic eczema.
Annelie H Musters, Soudeh Mashayekhi, Jane Harvey, Emma Axon, Stephanie J Lax

Cochrane Database Syst Rev· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amputations for extremity soft tissue sarcoma in an era of limb salvage treatment: Local control and survival.
Marc G Stevenson, Annelie H Musters, Jan H B Geertzen, Barbara L van Leeuwen, Harald J Hoekstra

J Surg Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis